Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Gastroenterology
31 Oct 2016
An interview with Julie Iven at UEG Week Vienna 2016
An interview with Julie Iven (Translational Research Center for Gastrointestinal Disorders) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
An interview with Dr Jan Tack at UEG Week Vienna 2016
An interview with Dr Jan Tack (Professor of Gastroenterology, University Hospital of Leuven) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
An interview with Dr Dina Tiniakos at UEG Week Vienna 2016
An interview with Dr Dina Tiniakos (Clinical Senior Lecturer/Hon, Consultant in Cellular Pathology) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
An interview with Prof Janneke van der Woude at UEG Week Vienna 2016
An interview with Prof Janneke van der Woude (Gastroenterology and Liver Department, Erasmus MC, Rotterdam) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
Congress Review – UEG Week Vienna 2016
Don’t miss our congress review in our EMJ Gastroenterology 5.1 2016 eJournal, coming soon…
Diabetes
26 Oct 2016
Congress Review – EASD 2016
Read our congress review in our EMJ Diabetes 4.1 2016 eJournal, available now…
Diabetes
26 Oct 2016
An interview with Prof Dr Coen Stehouwer at the 2016 EASD Congress
An interview with Prof Dr Coen Stehouwer (Professor of Medicine and Chair, Department of Internal Medicine) at the 2016 EASD Congress, Munich, Germany.
Diabetes
26 Oct 2016
An interview with Prof Vilma Urbančič-Rovan at the 2016 EASD Congress
An interview with Prof Vilma Urbančič-Rovan (Head of the Diabetes Unit, University Medical Centre Ljubljana) at the 2016 EASD Congress, Munich, Germany.
Dermatology
26 Oct 2016
An interview with Prof Chris Griffiths at the 2016 EADV Congress
An interview with Prof Chris Griffiths (Professor of Dermatology, University of Manchester) at the 2016 EADV Congress, Vienna, Austria.
Dermatology
26 Oct 2016
An interview with Prof Torello M. Lotti at the 2016 EADV Congress
An interview with Prof Torello M. Lotti (Professor and Chair of Dermatology, University of Rome) at the 2016 EADV Congress, Vienna, Austria.
Dermatology
26 Oct 2016
Congress Review – EADV 2016
Don’t miss our congress review in our EMJ Dermatology 4.1 2016 eJournal, coming soon…
Diabetes
26 Oct 2016
An interview with Dr Lorenzo Pasquali at the 2016 EASD Congress
An interview with Dr Lorenzo Pasquali (Junior Group Leader, Department of Endocrinology) at the 2016 EASD Congress, Munich, Germany.
Urology
29 Sep 2016
GreenLight XPS™Laser Therapy System: A True Day Case Procedure
The National Institute for Clinical Health Care and Excellence (NICE) has given favourable guidance for GreenLight XPS™, advising that is Cost Saving…
Cardiology
27 Sep 2016
An interview with Dr Carl Lavie at the 2016 ESC Congress
An interview with Dr Carl Lavie (Medical Director, Cardiac Rehabilitation and Prevention) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
An interview with Dr Javed Butler at the 2016 ESC Congress
An interview with Dr Javed Butler (Chief of the Cardiology Division, Stony Brook University) at the 2016 European Society of Cardiology Congress, Rome…
Cardiology
27 Sep 2016
An interview with Dr Bill Sasiela at the 2016 ESC Congress
An interview with Dr Bill Sasiela (Regeneron Pharmaceuticals, New York, USA) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
An interview with Dr Jay Elberg at the 2016 ESC Congress
An interview with Dr Jay Elberg (Head of Cardiovascular Development, Stanford) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
An interview with Dr Rahul Potluri at the 2016 ESC Congress
An interview with Dr Rahul Potluri (ACALM Study Unit, Aston Medical School) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
Congress Review – ESC 2016
Don’t miss our congress review in our EMJ Cardiology 4.1 2016 eJournal, coming soon…
Respiratory
27 Sep 2016
An interview with Dr Oliver Eickelberg at the 2016 ERS Congress
An interview with Dr Oliver Eickelberg (Chairman, Comprehensive Pneumology Center) at the 2016 European Respiratory Society Congress, London, United…
Respiratory
27 Sep 2016
An interview with Prof Nicholas Hill at the 2016 ERS Congress
An interview with Prof Nicholas Hill (Professor of Medicine, Tufts University) at the 2016 European Respiratory Society Congress, London, United Kingdom.
Respiratory
27 Sep 2016
Congress Review – ERS 2016
Don’t miss our congress review in our EMJ Respiratory 4.1 2016 eJournal, available now at: https://www.emjreviews.com/therapeutic-area/respiratory/
Neurology
19 Jul 2016
The Role of IL-6 in Autoimmune Disease
Rheumatoid arthritis, or RA, is an incompletely understood disorder. The complex pathophysiology of RA is regulated in part by a network of different…
Oncology
17 Jun 2016
Personalised screening for breast cancer care
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from…
Neurology
14 Jun 2016
EAN 2016 – Prof Günther Deuschl
Prof Gunther Deuschl’s press conference at EAN 2016.EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof John England – Part 2
Part 2 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…
Neurology
14 Jun 2016
EAN 2016 – Prof Raad Shakir – Part 1
Part 1 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…
Neurology
14 Jun 2016
EAN 2016 – Prof Mads Henrik Ravnborg
Prof Mads Henrik Ravnborg’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof Franz Fazekas
Prof Franz Fazekas’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof Gunhild Waldemar
Prof Gunhild Waldemar’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Dermatology
14 Jun 2016
Overview of ZPL-3893787 (ZPL-389) clinical trial for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, gives an overview of a phase 2a proof-of-concept clinical trial evaluating ZPL…
Dermatology
14 Jun 2016
Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…
Urology
14 Jun 2016
Innovation in Education – EAU 2016
Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now…
Oncology
14 Jun 2016
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…
Oncology
14 Jun 2016
Impact of phase 3 PlanB trial on evidence-based clinical practice for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
5-year outcomes from PlanB: Phase 3 trial of 21-gene Recurrence Score® result in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Urology
14 Jun 2016
An interview with Professor Theo M. de Reijke at the 2016 EAU Congress
An interview with Professor Theo M. de Reijke (Academic Medical Center, Amsterdam, Netherlands) at the 2016 European Association of Urology Congress…
Urology
14 Jun 2016
An interview with Doctor Evangelos Liatsikos at the 2016 EAU Congress
An interview with Doctor Evangelos Liatsikos (University of Patras, Patras, Greece) at the 2016 European Association of Urology Congress, Munich, Germany.
Urology
14 Jun 2016
An interview with Doctor Murat Arslan at the 2016 EAU Congress
An interview with Doctor Murat Arslan (Izmir University, Izmir, Turkey) at the 2016 European Association of Urology Congress, Munich, Germany.
Urology
14 Jun 2016
Congress Review – EAU 2016
Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now at…
Urology
14 Jun 2016
Breast cancer in Europe: Epidemiology and outcomes
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jan-Willem Coebergh, MD, PhD, from…
Oncology
14 Jun 2016
Defining factors that can predict neoadjuvant chemotherapy response in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
Oncology
14 Jun 2016
Genetically determining susceptibility of breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the…
Oncology
14 Jun 2016
Surgical considerations after neoadjuvant treatment for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
Oncology
14 Jun 2016
Individualisation of breast cancer therapy
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
Hepatology
14 Jun 2016
ILC 2016 – Dr. James Freeman
Dr. James Freeman’s press conference on ‘High Sustained Virological Response Rates Using Direct Acting Antiviral Treatment For Hepatitis C, Imported Into…
Hepatology
14 Jun 2016
ILC 2016 – Dr. Stefano Brillanti
Dr. Stefano Brillanti’s press conference on ‘Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals’ at…
Hepatology
14 Jun 2016
ILC 2016 – Dr. Stephen Atkinson
Dr. Stephen Atkinson’s press conference on ‘A Genome-Wide Association Study Identifies PNPLA3 and SLC38A4 as Risk LOCI For Alcoholic Hepatitis’ at ILC 2016.
Hepatology
14 Jun 2016
Congress Review – ILC 2016
Don’t miss our congress review in our EMJ Hepatology 4.1 2016 eJournal, coming soon. Subscribe today at…
Hepatology
14 Jun 2016
An interview with Professor Jean-Francois Dufour at the 2016 ILC Congress
An interview with Professor Jean-Francois Dufour (University Clinic Visceral Surgery and Medicine, Bern, Switzerland) at the 2016 International Liver…
Hepatology
14 Jun 2016
An interview with Professor Marina Berenguer at the 2016 ILC Congress
An interview with Professor Marina Berenguer (University of Valencia, Valencia, Spain) at the 2016 International Liver Congress, Barcelona, Spain.
Hepatology
14 Jun 2016
An interview with Professor Cecilia Rodrigues at the 2016 ILC Congress
An interview with Professor Cecilia Rodrigues (University of Lisbon, Lisbon, Portugal) at the 2016 International Liver Congress, Barcelona, Spain.
Allergy & Immunology
14 Jun 2016
SUPREMO Trial: Pathology Quality Assurance
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jeremy Thomas, MD, from…
Oncology
14 Jun 2016
Opportunities for improved outcomes in breast cancer patients
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from…
Oncology
14 Jun 2016
2005–2015 global analysis of advanced breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD…
Oncology
14 Jun 2016
Imaging biomarkers as a predictive tool in breast cancer management
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
Oncology
14 Jun 2016
Abstracts from the 10th European Breast Cancer Conference
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
Oncology
14 Jun 2016
Checkpoint inhibitors for triple-negative breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Precision medicine for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Highlights of the 10th European Cancer Conference (EBCC-10) by Dr Giuseppe Curigliano
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Themes of the 10th European Breast Cancer Conference (EBCC-10)
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
Oncology
14 Jun 2016
Understanding the unique aspects of immunotherapy for lung cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
Oncology
14 Jun 2016
Immunotherapy for head and neck cancer
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
Oncology
14 Jun 2016
Improving the treatment of advanced renal cell carcinoma
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
Oncology
14 Jun 2016
Predictive biomarkers for immunotherapy in non-small cell lung cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
Oncology
14 Jun 2016
Next-generation sequencing to guide treatment decision-making
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
Oncology
14 Jun 2016
Introducing next-generation sequencing into the clinical care of cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
Oncology
14 Jun 2016
Early versus delayed use of tyrosine kinase inhibitors for thyroid cancer
Recent advances in the biological understanding of thyroid cancer have led to the development of targeted therapies, such as the tyrosine kinase…
Oncology
14 Jun 2016
Updating the treatment algorithm for metastatic melanoma
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
Oncology
14 Jun 2016
Changing the treatment landscape of metastatic melanoma
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
Oncology
14 Jun 2016
Clinical decision-making for pancreatic cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
Oncology
14 Jun 2016
The significance of BRCA mutations in pancreatic cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
Oncology
14 Jun 2016
Treatment of pancreatic cancer: Overview of the continued progress
Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from…
Hematology
13 Jun 2016
The DA-EPOCH-R clinical trial in Burkitt’s lymphoma
Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA, gives an overview of the interim analysis of a multicenter prospective…
Oncology
25 May 2016
KEYNOTE-010: Pembrolizumab versus docetaxel in advanced PD-L1-positive NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
ASCEND-2 and ASCEND-3 trials: Ceritinib in ALK-rearranged NSCLC with brain metastases
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
Immune checkpoint inhibitors, durvalumab plus tremelimumab, for non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
Immunotherapy for hepatocellular carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Su Pin Choo, MBBS…
Oncology
25 May 2016
Phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD…
Oncology
25 May 2016
Endocrine therapy in pregnant women with breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
Oncology
25 May 2016
Olaparib and bevacizumab: On the horizon for treating ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Suresh Kumarasamy, MBBS…
Oncology
25 May 2016
Tumour biomarker changes after neoadjuvant chemotherapy in breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
Oncology
25 May 2016
From biologics to biosimilars
A biosimilar can be defined as a biological product that demonstrates no clinically meaningful differences to an approved biological product. At the…
Rheumatology
19 Apr 2016
Treating Active HIDS with Canakinumab
The efficacy and safety of canakinumab in active hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS) and the implications of the results for the future treatment of patients with the condition.
Rheumatology
19 Apr 2016
Pathophysiology and Treatment of HIDS
At the American College of Rheumatology Annual Meeting, topic of interest is the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)
Oncology
19 Apr 2016
Canakinumab in the treatment of tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…
Loading posts...
« Previous
1
…
48
49
50
51
52
…
92
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View